1157 GMT - Danone could have an improvement in its infant-nutrition segment driven by the rise in birth rates in China, Barclays analysts say in a note. Especially given its material presence and significant market-share gains, the analysts add. After eight years of declines, China's National Bureau of Statistics recorded a birth rate increase of around 6% in 2024, they say. China accounts for roughly 40% of Danone's total infant-nutrition sales, the analysts say. Aptamil is the biggest brand across its entire portfolio, with sales of more than 3 billion euros, they say. China accounts for 50% of the global infant-formula market by value, and Danone currently holds a 13% market share, they say. However, it remains uncertain whether the increasing birth rate is a change in the trend or a mostly horoscope-related effect, as 2024 was the Year of the Dragon--a period which is traditionally associated with good fortune in Chinese culture, Barclays says. Shares are up 0.6% at 65.30 euros. (michael.susin@wsj.com)
(END) Dow Jones Newswires
January 20, 2025 06:57 ET (11:57 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。